U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H28N2O.ClH
Molecular Weight 384.942
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BL-1021

SMILES

Cl.CN(CCC=C1C2=C(CCC3=C1C=CC=C3)C=CC=C2)C(=O)CCCN

InChI

InChIKey=DEKZAWRGNGHZKY-UHFFFAOYSA-N
InChI=1S/C23H28N2O.ClH/c1-25(23(26)13-6-16-24)17-7-12-22-20-10-4-2-8-18(20)14-15-19-9-3-5-11-21(19)22;/h2-5,8-12H,6-7,13-17,24H2,1H3;1H

HIDE SMILES / InChI
Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula C23H28N2O
Molecular Weight 348.4812
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

BL-1021 was developed by BioLineRx Ltd. for the treatment of neuropathic pain or pain that results from damage to nerve fibers. The drug has completed phase I clinical trials, however further information is not available.

Originator

Approval Year

Unknown
139594

Sample Use Guides

In Vivo Use Guide
a single administration of BL-1021 at doses between 10mg and 80mg in healthy volunteers.
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 10:07:15 GMT 2023
Edited
by admin
on Sat Dec 16 10:07:15 GMT 2023
Record UNII
7Q35V52Q2Z
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BL-1021
Common Name English
BUTANAMIDE, 4-AMINO-N-(3-(10,11-DIHYDRO-5H-DIBENZO(A,D)CYCLOHEPTEN-5-YLIDENE)PROPYL)-N-METHYL-, HYDROCHLORIDE (1:1)
Systematic Name English
Code System Code Type Description
CAS
1002331-76-1
Created by admin on Sat Dec 16 10:07:15 GMT 2023 , Edited by admin on Sat Dec 16 10:07:15 GMT 2023
PRIMARY
PUBCHEM
24898306
Created by admin on Sat Dec 16 10:07:15 GMT 2023 , Edited by admin on Sat Dec 16 10:07:15 GMT 2023
PRIMARY
FDA UNII
7Q35V52Q2Z
Created by admin on Sat Dec 16 10:07:15 GMT 2023 , Edited by admin on Sat Dec 16 10:07:15 GMT 2023
PRIMARY
Related Record Type Details
Structure of BL-1021 FREE BASE
PARENT -> SALT/SOLVATE
Related Record Type Details
Structure of BL-1021 FREE BASE
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966